Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Riccardo Caraffi"'
Autor:
Ilaria Ottonelli, Jason Thomas Duskey, Filippo Genovese, Francesca Pederzoli, Riccardo Caraffi, Marta Valenza, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi
Publikováno v:
International Journal of Pharmaceutics: X, Vol 5, Iss , Pp 100182- (2023)
Externí odkaz:
https://doaj.org/article/e2ad55e74cb94311a24b3ee30c22633c
Autor:
Giulia Birolini, Marta Valenza, Ilaria Ottonelli, Francesca Talpo, Lucia Minoli, Andrea Cappelleri, Mauro Bombaci, Claudio Caccia, Caterina Canevari, Arianna Trucco, Valerio Leoni, Alice Passoni, Monica Favagrossa, Maria Rosaria Nucera, Laura Colombo, Saverio Paltrinieri, Renzo Bagnati, Jason Thomas Duskey, Riccardo Caraffi, Maria Angela Vandelli, Franco Taroni, Mario Salmona, Eugenio Scanziani, Gerardo Biella, Barbara Ruozi, Giovanni Tosi, Elena Cattaneo
Publikováno v:
Pharmacological Research, Vol 194, Iss , Pp 106823- (2023)
Evidence that Huntington's disease (HD) is characterized by impaired cholesterol biosynthesis in the brain has led to strategies to increase its level in the brain of the rapidly progressing R6/2 mouse model, with a positive therapeutic outcome. Here
Externí odkaz:
https://doaj.org/article/96c6f98820c54018a225e99542b0010a
Autor:
Ilaria Ottonelli, Jason Thomas Duskey, Filippo Genovese, Francesca Pederzoli, Riccardo Caraffi, Marta Valenza, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi
Publikováno v:
International Journal of Pharmaceutics: X, Vol 4, Iss , Pp 100136- (2022)
Nanoparticles (NPs) are paving the way for improved treatments for difficult to treat diseases diseases; however, much is unknown about their fate in the body. One important factor is the interaction between NPs and blood proteins leading to the form
Externí odkaz:
https://doaj.org/article/a27122d27e39445c892e505b5b7cf0b2
Autor:
Marzia Moretti, Riccardo Caraffi, Luca Lorenzini, Ilaria Ottonelli, Michele Sannia, Giuseppe Alastra, Vito Antonio Baldassarro, Alessandro Giuliani, Jason Thomas Duskey, Maura Cescatti, Barbara Ruozi, Luigi Aloe, Maria Angela Vandelli, Luciana Giardino, Giovanni Tosi, Laura Calzà
Publikováno v:
Cells, Vol 12, Iss 9, p 1331 (2023)
Spinal cord injury (SCI) is characterized by a cascade of events that lead to sensory and motor disabilities. To date, this condition is irreversible, and no cure exists. To improve myelin repair and limit secondary degeneration, we developed a multi
Externí odkaz:
https://doaj.org/article/59aa99aac00f4692af8891a3ebe9739f
Autor:
Ilaria Ottonelli, Andrea Bighinati, Elisa Adani, François Loll, Riccardo Caraffi, Maria Angela Vandelli, Frank Boury, Giovanni Tosi, Jason Thomas Duskey, Valeria Marigo, Barbara Ruozi
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 25 (2022)
A drawback in the development of treatments that can reach the retina is the presence of barriers in the eye that restrain compounds from reaching the target. Intravitreal injections hold promise for retinal delivery, but the natural defenses in the
Externí odkaz:
https://doaj.org/article/c6c2d3deb8b74808b640c4a0b3e61ce3
Autor:
Jason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, Riccardo Caraffi, Chiara Alessia De Benedictis, Ann Katrin Sauer, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi, Andreas Martin Grabrucker
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1450 (2022)
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of currently used drugs represent major barriers that need to be overcom
Externí odkaz:
https://doaj.org/article/540be991bcc843d3bfd60207a7ececc9
Autor:
Francesca Rodà, Riccardo Caraffi, Silvia Picciolini, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi, Marzia Bedoni, Ilaria Ottonelli, Jason Thomas Duskey
Glioblastoma multiforme (GBM) is the most common malignant brain tumor, associated with low long-term survival. Nanoparticles (NPs) developed against GBM are a promising strategy to improve current therapies, by enhancing the brain delivery of active
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455cf173a7784ce40beb03e5f2928147
https://hdl.handle.net/11380/1302168
https://hdl.handle.net/11380/1302168
Autor:
Jason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, Riccardo Caraffi, Chiara Alessia De Benedictis, Ann Katrin Sauer, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi, Andreas Martin Grabrucker
Publikováno v:
Pharmaceutics; Volume 14; Issue 7; Pages: 1450
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of currently used drugs represent major barriers that need to be overcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be2dce092e8be526610ddcff788c3b9
Autor:
Marta Valenza, Giulia Birolini, Ilaria Ottonelli, Francesca Talpo, Alice Passoni, Monica Favagrossa, Laura Colombo, Riccardo Caraffi, Claudio Caccia, Valerio Leoni, Franco Taroni, Andrea Cappelleri, Lucia Minoli, Saverio Paltrinieri, Eugenio Scanziani, Barbara Ruozi, Mario Salmona, Gerardo Biella, Giovanni Tosi, Elena Cattaneo
Publikováno v:
I: Experimental therapeutics – preclinical.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbee1c2fc74be8e308c53b98ddef417e
https://doi.org/10.1136/jnnp-2022-ehdn.243
https://doi.org/10.1136/jnnp-2022-ehdn.243
Autor:
Giulia Birolini, Marta Valenza, Ilaria Ottonelli, Francesca Talpo, Lucia Minoli, Andrea Cappelleri, Mauro Bombaci, Claudio Caccia, Caterina Canevari, Arianna Trucco, Valerio Leoni, Alice Passoni, Monica Favagrossa, Maria Rosaria Nucera, Laura Colombo, Saverio Paltrinieri, Renzo Bagnati, Jason Thomas Duskey, Riccardo Caraffi, Maria Angela Vandelli, Franco Taroni, Mario Salmona, Eugenio Scanziani, Gerardo Biella, Barbara Ruozi, Giovanni Tosi, Elena Cattaneo
Evidence that Huntington’s disease (HD) is characterized by impaired cholesterol biosynthesis in the brain has led to strategies to increase its level in the brain of the rapidly progressing R6/2 mouse model, with a positive therapeutic outcome. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a6abca71fc6783e9930190ce9c573c5
https://doi.org/10.1101/2022.08.26.505426
https://doi.org/10.1101/2022.08.26.505426